Metraipolis › archive › dc_779c1da1f0cb

Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis — Europe PMC PMID:42649870

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42649870
DOI
10.3390/cancers18162555
License (as archived)
solo-consultazione
Archived
2026-10-16T22:30:48.408Z
SHA-256 of the archived text
73d853d417bfe87866aafde4d7e2b999a9f8a56517d576f9f214c30eb583b20e
Stable URL of this page
https://metraipolis.com/documento/dc_779c1da1f0cb

How to cite

Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis — Europe PMC PMID:42649870 — Europe PMC (en), https://europepmc.org/article/MED/42649870 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_779c1da1f0cb (Metraipolis archive dc_779c1da1f0cb, sha256 73d853d417bfe87866aafde4d7e2b999a9f8a56517d576f9f214c30eb583b20e)
BibTeX
@misc{dc779c1da1f0cb,
  title = {Real-World Efficacy and Safety of Gemcitabine, Cisplatin, Plus Immune Checkpoint Inhibitors in Biliary Tract Cancer: A Retrospective Analysis — Europe PMC PMID:42649870},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42649870},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_779c1da1f0cb; sha256 73d853d417bfe87866aafde4d7e2b999a9f8a56517d576f9f214c30eb583b20e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649870. Agents can read the archived copy with the MCP tool read_document.